Advertisement

Cord immunoproteins as predictors of respiratory outcome in preterm infants

Published:November 25, 2008DOI:https://doi.org/10.1016/j.ajog.2008.07.070

      Objective

      The purpose of this study was to evaluate the role of cord blood proteins and antenatal factors in the prediction of respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD).

      Study Design

      The prospectively collected cohort included 163 infants. All infants were born between 1998-2002 in a single regional hospital before 32 weeks of gestation and survived the first hospitalization. Altogether, 107 cord blood proteins were analyzed. Twenty-two antenatal clinical factors were included in the data mining and logistic regression analyses.

      Results

      The incidence of RDS was 64% and of BPD was 25%. Histologic chorioamnionitis protected from RDS (odds ratio [OR], 0.24; 95% confidence interval [CI], 0.11-0.53; P < .001). Besides the length of gestation, other clinical factors poorly predicted the outcomes. Matrix metalloproteinase-9 independently predicted RDS (OR, 8.3; 95% CI, 3.0-23.1; P < .001). Soluble glycoprotein 130 independently predicted BPD (OR, 6.07; 95%CI, 2.20-16.7; P < .001).

      Conclusion

      Specific antenatal immunologic activation predicts either acute or chronic respiratory disease in very preterm infants.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dinarello C.A.
        Historical insights into cytokines.
        Eur J Immunol. 2007; 37: S34-S45
        • Mantovani A.
        • Bonecchi R.
        • Locati M.
        Tuning inflammation and immunity by chemokine sequestration: decoys and more.
        Nat Rev Immunol. 2006; 6: 907-918
        • Goldenberg R.L.
        • Hauth J.C.
        • Andrews W.W.
        Intrauterine infection and preterm delivery.
        N Engl J Med. 2000; 342: 1500-1507
        • Gomez R.
        • Romero R.
        • Ghezzi F.
        • Yoon B.H.
        • Mazor M.
        • Berry S.M.
        The fetal inflammatory response syndrome.
        Am J Obstet Gynecol. 1998; 179: 194-202
        • Leviton A.
        • Paneth N.
        • Reuss M.L.
        • et al.
        Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants: developmental epidemiology network investigators.
        Pediatr Res. 1999; 46: 566-575
        • Watterberg K.
        • Demeres L.M.
        • Scott S.M.
        • Murphy S.
        Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.
        Pediatrics. 1996; 97: 210-215
        • Yoon B.H.
        • Jun J.K.
        • Romero R.
        • et al.
        Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy.
        Am J Obstet Gynecol. 1997; 177: 19-26
        • Nelson K.B.
        • Dambrosia J.M.
        • Grether J.K.
        • Philips T.M.
        Neonatal cytokines and coagulation factors in children with cerebral palsy.
        Ann Neurol. 1998; 44: 665-675
        • Saliba E.
        • Marret S.
        Cerebral white matter damage in the preterm infant: pathophysiology and risk factors.
        Semin Neonatol. 2001; 6: 121-133
        • Speer C.P.
        Inflammation and bronchopulmonary dysplasia: a continuing story.
        Semin Fetal Neonatal Med. 2006; 11: 354-362
        • Hallman M.
        • Glumoff V.
        • Rämet M.
        Surfactant in respiratory distress syndrome and lung injury.
        Comp Biochem Physiol A Mol Integr Physiol. 2001; 129: 287-294
        • Bry K.
        • Lappalainen U.
        • Hallman M.
        Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth.
        J Clin Invest. 1997; 99: 2992-2999
        • Buntinx M.
        • Gielen E.
        • van Hummelen P.
        • et al.
        Cytokine-induced cell death in human oligodendroglial cell lines.
        J Neurosci Res. 2004; 76: 846-861
        • Conroy S.M.
        • Nguyen V.
        • Quina L.A.
        • et al.
        Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures.
        J Neuroimmunol. 2004; 155: 43-54
        • Glumoff V.
        • Väyrynen O.
        • Kangas T.
        • Hallman M.
        Degree of lung maturity determines the direction of the interleukin-1-induced effect on the expression of surfactant proteins.
        Am J Respir Cell Mol Biol. 2000; 22: 280-288
        • Kaukola T.
        • Herva R.
        • Perhomaa M.
        • et al.
        Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants.
        Pediatr Res. 2006; 59: 478-483
        • Benirschke K.
        • Kauffmann P.
        Pathology of the human placenta.
        Springer-Verlag, New York2000 (16-28, 425, 453-6, 591-608)
        • Walsh M.C.
        • Yao Q.
        • Gettner P.
        • et al.
        Impact of a physiologic definition on bronchopulmonary dysplasia rates.
        Pediatrics. 2004; 114: 1305-1311
        • Schweitzer B.
        • Roberts S.
        • Grimwade B.
        • et al.
        Multiplexed protein profiling on microarrays by rolling-circle signal amplification.
        Nat Biotechnol. 2002; 20: 359-365
        • Venables W.N.
        • Ripley B.D.
        Modern applied statistics with S.
        Springer-Verlag, New York2002
        • Eisen M.B.
        • Spellman P.T.
        • Brown P.O.
        • Botstein D.
        Cluster analysis and display of genome-wide expression patterns.
        Proc Natl Acad Sci U S A. 1998; 25: 14863-14868
        • R Core Development Team
        R: a language and environment for statistical computing.
        R Foundation for Statistical Computing, Vienna, Austria2008
        • Therneau T.M.
        • Atkinson B.
        R port by Ripley B.
        (Accessed Sept. 13, 2008)
        • Dempsey E.
        • Chen M.F.
        • Kokottis T.
        • Vallerand D.
        • Usher R.
        Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis.
        Am J Perinatol. 2005; 22: 155-159
        • Jobe A.H.
        • Newnham J.P.
        • Willet K.E.
        • et al.
        Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs.
        Am J Obstet Gynecol. 2000; 182: 401-418
        • Parks W.C.
        • Wilson C.L.
        • López-Boado Y.S.
        Matrix metalloproteinases as modulators of inflammation and innate immunity.
        Nature Rev. 2004; 4: 617-629
        • Kim K.H.
        • Burkhart K.
        • Chen P.
        • et al.
        Tissue inhibitor of metaloproteinase-1 deficiency amplifies acute lung injury in bleomycin exposed mice.
        Am J Respir Cell Mol Biol. 2005; 33: 271-279
        • Hariah H.
        • Donia S.E.
        • Hsu C.D.
        Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection.
        Obstet Gynecol. 2002; 99: 80-84
        • Dik W.A.
        • van Kaam A.H.L.C.
        • Dekker T.
        • et al.
        Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome.
        Biol Neonate. 2006; 89: 6-14
        • Warburton D.
        • Gauldie J.
        • Bellusci S.
        • Shi W.
        Lung development and susceptibility to chronic obstructive pulmonary disease.
        Proc Am Thorac Soc. 2006; 3: 668-672
        • Miyazaki E.
        • Nureki S.
        • Ono E.
        • et al.
        Circulating thymus- and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury.
        Chest. 2007; 131: 1726-1734
        • Berin M.C.
        The role of TARC in the pathogenesis of allergic asthma.
        Drug News Perspect. 2002; 15: 10-16
        • Kaukola T.
        • Satyaraj E.
        • Patel D.D.
        • et al.
        Cerebral palsy is characterized by protein mediators in cord serum.
        Ann Neurol. 2004; 55: 186-194
        • Yoon B.H.
        • Romero R.
        • Kim K.S.
        • et al.
        A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia.
        Am J Obstet Gynecol. 1999; 181: 773-779
        • Mittendorf R.
        • Covert R.
        • Montag A.G.
        • et al.
        Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates.
        J Perinat Med. 2005; 33: 428-434
        • Moss T.J.M.
        • Newnham J.P.
        • Willett K.E.
        • Kramer B.W.
        • Jobe A.H.
        • Ikegami M.
        Early gestational intra-amniotic endotoxin.
        Am J Respir Care Med. 2002; 165: 805-811
        • Kallapur S.G.
        • Bachurski C.J.
        • Le Cras T.D.
        • Joshi S.N.
        • Ikegami M.
        • Jobe A.H.
        Vascular changes after intra-amniotic endotoxin in preterm lamb lungs.
        Am J Physiol Lung Cell Mol Physiol. 2004; 287: L1178-L1185
        • Redline R.W.
        • Wilson-Costello D.
        • Hack M.
        Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants.
        Pediatr Res. 2002; 52: 713-719
        • Van Marter L.J.
        • Dammann O.
        • Allred E.N.
        • et al.
        Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants.
        J Pediatr. 2002; 140: 171-176
        • Montero-Julian F.A.
        The soluble IL-6 receptors: serum levels and biologic function.
        Cell Mol Biol. 2001; 47: 583-597